SUMMARY To evaluate whether abnormal production of type III collagen, the characteristic biochemical feature of patients with the type IV Ehiers-Danlos syndrome, consistently predisposes to mitral valve prolapse, we evaluated the family of a proband with classic type IV Ehlers-Danlos syndrome. Production of type III collagen was assessed with the use of cultured skin fibroblasts. Mitral valve prolapse was detected by M-mode and two-dimensional echocardiography. Biochemical abnormalities in the production of type III collagen and echocardiographic findings of mitral valve prolapse were completely concordant. All patients with abnormal production of type III collagen had mitral valve prolapse and all subjects with normal production of type III collagen had entirely normal echocardiograms. Six of the eight patients with abnormal production of type III collagen had subtle cutaneous abnormalities. The consistent association of abnormal production of type III collagen and mitral valve prolapse in this family suggests that this abnormality of collagen may give rise to mitral valve prolapse.
MITRAL VALVE PROLAPSE (MVP) is a heterogeneous clinical syndrome that affects 5% or more of the population." 2 Since the syndrome was described originally, the pathologic anatomy, auscultatory and echocardiographic correlates, symptoms, natural history and several associated abnormalities have been reported.2'-Despite this extensive body of information, the molecular basis and etiologies of mitral valve prolapse are obscure. Speculation about pathogenesis has led to attempts to correlate the etiology of mitral valve prolapse with concomitant cardiac abnormalities or systemic diseases.6 Several disorders that affect the production or structure of collagen or that involve connective tissue in general, such as the Ehlers-Danlos syndrome, Marfan's syndrome, relapsing polychondritis and lupus erythematosus, have been associated with mitral valve prolapse. These associations and the presence of disordered collagen noted pathologically in the mitral valves of patients with mitral valve prolapse has led to the hypothesis that abnormal connective tissue in the mitral valve apparatus may be of pathogenetic importance in the develop- 
Dermatologic Findings
Two subjects, identical twins who were 16 years old, had marked cutaneous abnormalities, including thin, translucent and hyperextensible skin, easy bruisability, multiple molluscum pseudotumors over the knees, elbows and buttocks and mild hyperextensibility of the digits. Similar findings had been described in the maternal grandfather. One of the twins also had recurrent bilateral pneumothorax and hip dislocation. Six siblings and the mother reported no history of skin abnormalities. In five siblings and the mother no obvious skin abnormalities were detected by several examiners. However, two dermatologists experienced in evaluating patients with Ehlers-Danlos syndrome and unaware of the echocardiographic findings and biochemical analysis evaluated these six subjects independently and found mild hyperextensibility and increased velvetyness of the skin in all six. The results of dermatologic examination in the father and one sibling were considered normal by all examiners.
No subject had stigmata of Marfan's syndrome.
Echocardiographic Results
The echocardiographic findings are summarized in table 1 . The M-mode echocardiogram and a simultaneous phonocardiogram from the propositus is shown in figure 1A . The two-dimensional echocardiogram of his twin brother is shown in figure 1B . Eight of the 10 members of the family were found to have mitral valve prolapse by two-dimensional echocardiographic examination. In all cases, coaptation of one or both mitral valve leaflets was posterior to the mitral valve annulus and two also had systolic curling of the posterior mitral valve leaflet. Of the eight family members with mitral valve prolapse by two-dimensional echocardiography, only the twins and one other sibling had definite mitral valve prolapse detected by M-mode echocardiography. Three of the other subjects had M-mode echocardiograms that were highly suggestive of mitral valve prolapse. In the remaining two family members, only limited views of the mitral valve during systole could be obtained. The twins were the only family members who had additional echocardiographic abnormalities; both had a mildly increased diameter of the proximal aortic root.
Physical Examination
The findings on physical examination are summarized in table 1. The auscultatory findings in the propositus are shown in figure IA along with a simultaneous M-mode echocardiogram. All subjects with 122 CIRCULATION 
Studies of Collagen
Studies evaluating the production of type ILL collagen are shown in figure 2. Production of type ILL collagen was 21.53 + 2.0% (+ SD) of total production for eight determinations of control (range 18.8-25.5%). Seven family members had definitely abnormal production of type III collagen (greater than 2 standard deviations below the mean for controls) and two subjects had normal production of type III collagen (less than 2 standard deviations below the mean for controls and higher than production in at least one control subject). One subject had a diminution in the production of type III collagen (17.8% of total production, or 83% of the mean for controls) that was slightly less than 2 standard deviations below the mean for control subjects; however, because this value was less than all of the determinations of control, production of type Ill collagen was designated as abnormal. The mean production of type III collagen in subjects with abnormal production was 12.08 ± 3.7% (A SD) of total production, or 56.5 ± 18% (± SD) of the mean for controls. Each subject with abnormal production of type III collagen had echocardiographic evidence of mitral valve prolapse and at least subtle cutaneous abnormalities (figure 3). The two subjects with mitral valve prolapse and obvious cutaneous abnormalities produced 11.5% and 7.5% of their total collagen production as type III collagen, or 53% and 35%, respectively, of the mean production for control subjects, whereas patients with mitral valve prolapse and subtle cutaneous changes produced 13.1 ± 4% (i so) type III collagen, or 61 ± 19% (± SD) of the mean for controls.
Determinations of Haplotype
No consistent pattern of inheritance could be determined by evaluation of A and B antigens. The HLA-A-B13 pattern seen in one other family with type IV Ehiers-Danlos syndrome"' was absent, as was the A3 antigen, which has been associated with mitral valve prolapse. HLA BW 35, which has also been associated with mitral valve prolapse,'5 was found in three subjects with mitral valve prolapse and in both subjects without evidence of mitral valve prolapse. All siblings inherited the A2 B15 haplotype from the mother, but this inheritance pattern did not discriminate between patients with and without mitral valve prolapse. Typing for DR specificity did not suggest a consistent pattern of inheritance for mitral valve prolapse or the cutaneous abnormalities. abnormalities from obvious to subtle and at least two distinct abnormal ultrastructural patterns of collagen.9 The extent of the defect of collagen is undefined. To the best of our knowledge, only patients with clinically detectable skin abnormalities have been evaluated biochemically. Although mitral valve prolapse in type IV Ehlers-Danlos syndrome has not been systematically investigated, we are unaware of patients with type IV who do not manifest mitral valve prolapse.
The results of this study show a concordance between mitral valve prolapse and abnormal production of type III collagen in patients with both phenotypically expressed and clinically occult type IV Ehlers-Danlos syndrome, and suggest a pathogenetic link between the characteristic biochemical abnormality of type IV Ehlers-Danlos syndrome and mitral valve prolapse. The probability that two independent autosomal dominant characteristics such as mitral valve prolapse and abnormal production of type III collagen could be inherited without a subject who manifests only one of these characteristics is 1 in 128. Because these and other data clearly show that the expression of the biochemical abnormality may be subtle and because type III collagen is more common in mitral valve tissue than in many other tissues, it is possible that mitral valve prolapse could be the only clinical manifestation of this biochemical abnormality. This expectation is supported in part by the work of Hammer and associates,7 who evaluated a patient with known mitral valve prolapse who underwent mitral valve replacement. They found an absence 
